Contribution of pristinamycin in the treatment of adult acute sinusitis in outpatients;Place de la pristinamycine dans le traitement des sinusites aigues de l'adulte en ville

Presse Medicale

Volumn 28, Issue SUPPL. 1, 1999, Pages 10-12

  Pessey, J J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFUROXIME AXETIL; PENICILLIN G; PLACEBO; PRISTINAMYCIN;

ADULT; ANTIBIOTIC THERAPY; BIOEQUIVALENCE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HAEMOPHILUS INFLUENZAE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTPATIENT; PENICILLIN RESISTANCE; RANDOMIZED CONTROLLED TRIAL; SINUSITIS; STREPTOCOCCUS PNEUMONIAE;

ACUTE DISEASE; ADULT; AGE FACTORS; AMBULATORY CARE; FEMALE; HUMANS; MALE; PLACEBOS; SINUSITIS; TREATMENT OUTCOME; VIRGINIAMYCIN;

EID: 0033523420     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (2)

1. Pessey JJ et al. Pristinamycine versus céfuroxime axétil dans le traitement de la sinusite aiguë de l'adulte. RICAI, 1998 ; 166/P1:142.
2. Negri MC et al. In vitro selective antibiotic concentrations of ß-lactams for penicillin-resistant Streptococcus pneumoniae populations. Antimicrob Agents Chemother 1994 ; 38:122-5.